Randomised trial comparing weight loss through lifestyle and GLP-1 receptor agonist therapy in people with MASLD
Moolla A. et al, (2025), JHEP Reports, 101363 - 101363
The ins and outs of liver fat metabolism: The effect of phenotype and diet on risk of intrahepatic triglyceride accumulation.
Smith K. et al, (2025), Exp Physiol
Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans.
Srnic N. et al, (2025), Dis Model Mech, 18
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.
Smith K. et al, (2024), Diabetologia, 67, 2555 - 2567
Greater oxidation of dietary linoleate compared to palmitate in humans following an acute high-carbohydrate diet.
Srnic N. et al, (2024), Clin Nutr, 43, 2305 - 2315
Dissociation between liver fat content and fasting metabolic markers of selective hepatic insulin resistance in humans
Westcott F. et al, (2024), European Journal of Endocrinology (EJE)
Ketogenic diet but not free-sugar restriction alters glucose tolerance, lipid metabolism, peripheral tissue phenotype, and gut microbiome: RCT.
Hengist A. et al, (2024), Cell Rep Med, 5
Defatting of donor transplant livers during normothermic perfusion-a randomised clinical trial: study protocol for the DeFat study.
Abbas SH. et al, (2024), Trials, 25
LDHB contributes to the regulation of lactate levels and basal insulin secretion in human pancreatic β cells.
Cuozzo F. et al, (2024), Cell Rep, 43
LDHB contributes to the regulation of lactate levels and basal insulin secretion in human pancreatic β cells
Hodson D., (2024), Cell Reports
LDHB contributes to the regulation of lactate levels and basal insulin secretion in human pancreatic β cells
Hodson D., (2024), Cell Reports
The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans.
Luukkonen PK. et al, (2023), Cell Metab, 35, 1887 - 1896.e5
Circadian regulation of liver metabolism: experimental approaches in human, rodent, and cellular models.
Daniels LJ. et al, (2023), Am J Physiol Cell Physiol, 325, C1158 - C1177
Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk
Westcott F. et al, (2023), Atherosclerosis, 117237 - 117237
Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD.
Marjot T. et al, (2023), Gut, 72, 1607 - 1619
MLX plays a key role in lipid and glucose metabolism in humans: evidence from in vitro and in vivo studies
NAGARAJAN S. et al, (2023), Metabolism: clinical and experimental
Detection and alterations of acetylcarnitine (AC) in human liver by 1 H MRS at 3T after supplementation with l-carnitine.
Savic D. et al, (2023), Magn Reson Med, 89, 1314 - 1322
Nutritional regulation of hepatic de novo lipogenesis in humans.
Cross E. et al, (2023), Curr Opin Clin Nutr Metab Care, 26, 65 - 71
11β-HSD1 inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial.
Othonos N. et al, (2023), Nat Commun, 14